Skip to content

The Effects of Intraoperative Dexmedetomidine Infusion on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02164448
Enrollment
92
Registered
2014-06-16
Start date
2014-06-30
Completion date
2015-01-31
Last updated
2015-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer Patients Undergoing Laparoscopic Gastrectomy

Keywords

dexmedetomidine, postoperative bowel movement, laparoscopic gastrectomy

Brief summary

The investigators hypothesized that sympatholytic effect of dexmedetomidine would attenuate the hemodynamic instability and decrease in the splanchnic blood flow caused by pneumoperitoneum during laparoscopic surgery. This study is to investigate the effect of intraoperative dexmedetomidine infusion on postoperative bowel movement in patients undergoing laparoscopic gastrectomy.

Interventions

DRUGthe dexmedetomidine group

the dexmedetomidine group: dexmedetomidine infusion from induction of anesthesia to end of surgery

DRUGthe control group

saline infusion from induction of anesthesia to end of surgery

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* patient between 20 and 65 of age with ASA physical status Ⅰ-Ⅲ * gastric cancer patient undergoing laparoscopic gastrectomy

Exclusion criteria

* ASA physical status Ⅳ * bradycardia (\< 60 bpm), arrhythmia * uncompensated heart failure * hepatic failure (Child-Pugh score B 이상) * renal failure (eGFR MDRD \< 60 ml/min/1.73m2)

Design outcomes

Primary

MeasureTime frameDescription
gas passingup to 1 weekTo evaluate the postoperative bowel movement, we will assess the time to first gas passing

Secondary

MeasureTime frameDescription
sips of water timeup to 1 weekTo evaluate the postoperative bowel movement, we will assess the time to resume water intake

Other

MeasureTime frameDescription
soft diet timeup to 1 weekTo evaluate the postoperative bowel movement, we will assess the time to resume soft diet intake

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026